eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | retinal vein occlusion |
| Comorbidity | |macular edema |
| Sentences | 176 |
| PubMedID- 23154502 | Purpose: to evaluate the long-term visual prognosis and complications of patients who received intravitreal ozurdex injections for the treatment of macular edema (me) due to retinal vein occlusion (rvo). |
| PubMedID- 23379834 | Changes of macular sensitivity and morphology after pars plana vitrectomy for macular edema with central retinal vein occlusion: a case series. |
| PubMedID- 21805173 | Association of electroretinogram and morphological findings in branch retinal vein occlusion with macular edema. |
| PubMedID- 22823029 | Bevacizumab, a monoclonal antibody against vascular endothelial growth factor (vegf), is widely used for the treatment of macular edema associated with central retinal vein occlusion (crvo). |
| PubMedID- 21866074 | Methods: the subjects were 44 branch retinal vein occlusion patients with macular edema and 16 controls. |
| PubMedID- 26305536 | Regional choroidal thickness changes in branch retinal vein occlusion with macular edema. |
| PubMedID- 24642474 | Exploring the morphological and functional retinal changes after dexamethasone intravitreal implant (ozurdex(r)) in macular edema due to retinal vein occlusion. |
| PubMedID- 25383828 | Results: initial ophthalmic examination showed bilateral central retinal vein occlusion with macular edema, including serous macular detachment in the left eye. |
| PubMedID- 26285577 | Conclusion: the possibility of an infrequent complication like macular hole should be considered for intravitreal ranibizumab for macular edema with branch retinal vein occlusion. |
| PubMedID- 26418442 | Evaluation of multiple dexamethasone intravitreal implants in patients with macular edema associated with retinal vein occlusion. |
| PubMedID- 21275514 | Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in macular edema with central retinal vein occlusion. |
| PubMedID- 24402616 | Purpose: to investigate the association between vitreomacular adhesion (vma) and the visual and anatomic outcomes of antivascular endothelial growth factor therapy for macular edema due to branch retinal vein occlusion (brvo). |
| PubMedID- 22668201 | Purpose: to report the functional and anatomical outcome of intravitreal bevacizumab (ivb) treatment for macular edema due to branch retinal vein occlusion (brvo) in a clinical setting. |
| PubMedID- 22358585 | Prospective multicenter study of visual outcomes following three different treatments for macular edema associated with branch retinal vein occlusion: a study by the japanese brvo study group. |
| PubMedID- 20653482 | Purpose: to evaluate secondary ocular hypertension after intravitreal injection of triamcinolone acetonide (ivta) with 2 mg/0.05 ml or 4 mg/0.1 ml for macular edema associated with retinal vein occlusion (rvo). |
| PubMedID- 22615698 | Resolution of persistent cystoid macular edema due to central retinal vein occlusion in a vitrectomized eye following intravitreal implant of dexamethasone 0.7 mg. |
| PubMedID- 24684060 | The article presents examination results of 26 patients with macular edema (me) due to retinal vein occlusion (rvo) before and 1 month after an intravitreal injection of ranibizumab (lucentis). |
| PubMedID- 23483492 | Treatment of macular edema associated with retinal vein occlusion using sustained-release dexamethasone implants in a clinical setting. |
| PubMedID- 22044337 | Rapid resolution of macular edema associated with central retinal vein occlusion using ranibizumab after failure with multiple bevacizumab injections. |
| PubMedID- 25960733 | The patient developed acute severe abdominal pain and nausea the day after ivb for retinal vein occlusion with macular edema, and massive lower gastrointestinal bleeding occurred. |
| PubMedID- 22876931 | Background: the influence of serous retinal detachment (srd) on visual acuity, macular sensitivity, and macular thickness is unclear after intravitreal injection of triamcinolone acetonide (ivta) for macular edema with branch retinal vein occlusion (brvo). |
| PubMedID- 23533707 | Effects of vitrectomy on recurrent macular edema due to branch retinal vein occlusion after intravitreal injection of bevacizumab. |
| PubMedID- 24967199 | Aqueous levels of erythropoietin in acute retinal vein occlusion with macular edema. |
| PubMedID- 24778755 | Branch retinal vein occlusion with sectoral cystoid macular edema in toxoplasmic chorioretinitis. |
| PubMedID- 24531560 | Association of electroretinogram and morphological findings in central retinal vein occlusion with macular edema. |
| PubMedID- 23709332 | Purpose: to report a case of macular pseudohole (mph) development after sustained-release dexamethasone intravitreal implant for chronic macular edema due to central retinal vein occlusion (crvo). |
| PubMedID- 21811207 | Three treatments for macular edema because of branch retinal vein occlusion: intravitreous bevacizumab or tissue plasminogen activator, and vitrectomy. |
| PubMedID- 22301066 | Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the horizon trial. |
| PubMedID- 23264870 | Cystoid macular edema due to retinal vein occlusion, diabetic macular edema and post cataract surgery, hyper-autofluorescent regions corresponding to cystic spaces of fluid accumulation can be identified. |
| PubMedID- 20703046 | Laser photocoagulation in a 'grid' pattern over the area, demonstrated as leaking by fa, remains the 'reference treatment for macular edema due to branch retinal vein occlusion', according to the recent results of the score trial. |
| PubMedID- 26428221 | Purpose: current treatment paradigms for macular edema associated with retinal vein occlusions (rvo) often involve initial treatment with anti-vascular endothelial growth factor (vegf) agents, then switching to intravitreal dexamethasone implant (idi; ozurdex, allergan, parsippany, nj) for poor responders. |
| PubMedID- 26431300 | Background and objective: to compare efficacy of monthly treatment with bevacizumab or ranibizumab for macular edema due to retinal vein occlusion. |
| PubMedID- 19956967 | Macular microcirculation before and after vitrectomy for macular edema with branch retinal vein occlusion. |
| PubMedID- 23355773 | Patients and methods: this retrospective, consecutive study examined 53 eyes of 53 patients with macular edema due to branch retinal vein occlusion in 25 patients (47.2%) and nonproliferative diabetic retinopathy in 28 patients (52.8%). |
| PubMedID- 21383939 | The dexamethasone implant is now emerging as a potential treatment for macular edema arising from retinal vein occlusion, diabetic retinopathy, and uveitis. |
| PubMedID- 25657578 | Comparison of single injection and three monthly injections of intravitreal bevacizumab for macular edema associated with branch retinal vein occlusion. |
| PubMedID- 25896233 | Aims: to evaluate changes in macular morphology and function after repeated intravitreal dexamethasone implant (ozurdex(r)) for macular edema (me) due to retinal vein occlusion (rvo). |
| PubMedID- 21629578 | Treatment of macular edema due to retinal vein occlusions. |
| PubMedID- 26395854 | macular edema due to retinal vein occlusion is the second most common cause of vascular vision impairment. |
| PubMedID- 21941500 | The data presented in this case report indicate that the dexamethasone implant has an immediate effect on macular edema due to retinal vein occlusion that sets in within the first 72 h following the intravitreal implantation of the drug. |
| PubMedID- 21468337 | Scott et al23 demonstrated that the correlation between oct-measured center point thickness, and visual acuity letter score was statistically significant, but this relationship was, at best, modest in patients with macular edema associated with retinal vein occlusions. |
| PubMedID- 22991926 | Retinal function and morphology in central retinal vein occlusion with macular edema. |
| PubMedID- 24515951 | In patients with macular edema due to retinal vein occlusion, intraocular il-18 levels increased significantly (p < 0.001) after treatment with ranibizumab particularly in patients with high baseline il-18 which correlated with good visual outcome (p < 0.05). |
| PubMedID- 21087958 | Predictors of short-term visual outcome after anti-vegf therapy of macular edema due to central retinal vein occlusion. |
| PubMedID- 26247458 | He developed a central retinal vein occlusion complicated by macular edema and received treatment with intravitreal bevacizumab, which led to resolution of the edema. |
| PubMedID- 19763601 | Background: to evaluate prognostic factors of response to intravitreal bevacizumab therapy of macular edema (me) due to central retinal vein occlusion (crvo) or branch retinal vein occlusion (brvo). |
| PubMedID- 23224127 | Purpose: the aim of this study was to evaluate the effects of intravitreal treatment with bevacizumab (ivb) compared with triamcinolone (ivt) in patients with macular edema due to branch retinal vein occlusion (brvo) depending on the duration of brvo. |
| PubMedID- 19430731 | We report a case of a 69-year-old male patient who came to our attention for macular edema in hemiretinal vein occlusion. |
| PubMedID- 21978179 | Intravitreal bevacizumab for macular edema due to central retinal vein occlusion: perfused vs. |
| PubMedID- 23764703 | This new technique is a promising treatment of macular edema due to central retinal vein occlusion. |